STAGE IVB THYROID GLAND ANAPLASTIC CARCINOMA AJCC V8
Clinical trials for STAGE IVB THYROID GLAND ANAPLASTIC CARCINOMA AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IVB THYROID GLAND ANAPLASTIC CARCINOMA AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IVB THYROID GLAND ANAPLASTIC CARCINOMA AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo shows promise for rare, deadly thyroid cancer
Disease control OngoingThis study tests a combination of two drugs, lenvatinib and pembrolizumab, in 25 people with advanced anaplastic thyroid cancer that cannot be surgically removed. The goal is to see if this treatment can shrink tumors and help patients live longer. Lenvatinib blocks enzymes that …
Matched conditions: STAGE IVB THYROID GLAND ANAPLASTIC CARCINOMA AJCC V8
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 11:39 UTC
-
Promising combo therapy targets deadly thyroid cancer
Disease control OngoingThis study tests whether adding the immunotherapy drug atezolizumab to standard chemotherapy can help people with aggressive thyroid cancers (anaplastic or poorly differentiated) live longer. About 50 adults with advanced or inoperable cancer will receive different drug combinati…
Matched conditions: STAGE IVB THYROID GLAND ANAPLASTIC CARCINOMA AJCC V8
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 11, 2026 20:52 UTC